Cargando…
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The respective ischemic and bleeding risks of early aspirin discontinuation following an acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) remain uncertain. We performed a prospero-registered review of randomized controlled trials (RCTs) comparing a P2Y(12) inhibitor-based si...
Autores principales: | Guedeney, Paul, Mesnier, Jules, Sorrentino, Sabato, Abcha, Farouk, Zeitouni, Michel, Lattuca, Benoit, Silvain, Johanne, De Rosa, Salvatore, Indolfi, Ciro, Collet, Jean-Philippe, Kerneis, Mathieu, Montalescot, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141190/ https://www.ncbi.nlm.nih.gov/pubmed/32138287 http://dx.doi.org/10.3390/jcm9030680 |
Ejemplares similares
-
Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult
por: Zendjebil, Sandra, et al.
Publicado: (2020) -
Cardiovascular Prevention in People Living With HIV: Is There a Rationale to Move Beyond Aspirin?
por: Silvain, Johanne, et al.
Publicado: (2022) -
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis
por: Bellemain-Appaix, Anne, et al.
Publicado: (2014) -
Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis
por: Kerneis, Mathieu, et al.
Publicado: (2020) -
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal
por: Spaccarotella, Carmen, et al.
Publicado: (2021)